article thumbnail

MOTAGON to Become the First Pharmaceutical Company in the Czech Republic to Supply Medical Cannabis Extracts to Patients

Cannabis Law Report

– August 11, 2022) – MOTAGON, a pharmaceutical company based in Prague and specializing in medical cannabis, has secured a ground-breaking agreement with Europe’s biggest indoor cannabis producer and one of the first cannabis extracts and formulations producers PHCANN INTERNATIONAL.

article thumbnail

The Pharmaceutical Industry’s Relationship With Cannabis

Kind Meds (Cannabis Education Blog)

Over the years, it has gone from being commonly used to a controversial topic. At the same time, the pharmaceutical industry has become one of the most powerful businesses in the country. Cannabis has had a long, changing history in the United States. Its current value sits at over one trillion dollars.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Heritage Cannabis Enters Exclusive Partnership to Commercialize Avicanna’s Evidence-Based Topical Products through Heritage’s Medical Opticann Brands

Cannabis Law Report

Exclusive licensing of certain of Avicanna’s advanced and evidence-based CBD topical products including its deep tissue and skin care formulations. The Branded Products include Avicanna’s proprietary cannabinoid topical formulations developed through years of extensive research by Avicanna’s team of scientists.

Topical 98
article thumbnail

Canopy Growth Divests Pharmaceutical C3 Cannabinoid Compound Company

Cannabis Law Report

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC ) has entered into an agreement to divest its subsidiary business, C³ Cannabinoid Compound Company GmbH (“C3”), to Dermapharm Holding SE (“Dermapharm”) (WKN: A2GS5D, ISIN: DE000A2GS5D8), a European pharmaceutical company headquartered in Grünwald, Germany.

article thumbnail

Hemp-derived CBD Vs Cannabis-derived CBD in topicals

Marijuanally

CBD is a hot topic these days. The FDA recently approved a CBD-based drug to help treat childhood epilepsy such as Dravet’s Syndrome which is difficult to treat with conventional pharmaceuticals. Strains that focus on CBD extraction, such as Charlotte’s Web , have been bred to have low amounts of THC and high amounts of CBD.

Topical 73
article thumbnail

Thailand: Chulalongkorn University Taps into Medical Cannabis and Expands the Product Line

Cannabis Law Report

Dr. Rungpetch Sakulbumrungsilp Dean of the Faculty of Pharmaceutical Sciences, Chulalongkorn University. Dr. Rungpetch Sakulbumrungsilp, Dean of the Faculty of Pharmaceutical Sciences, Chulalongkorn University, unlike the present in which many facets and aspects of cannabis are being studied in addition to the work of Chula C.A.N.S.,

article thumbnail

Hemp-derived CBD Vs Cannabis-derived CBD in topicals

Marijuanally

CBD is a hot topic these days. The FDA recently approved a CBD-based drug to help treat childhood epilepsy such as Dravet’s Syndrome which is difficult to treat with conventional pharmaceuticals. Strains that focus on CBD extraction, such as Charlotte’s Web , have been bred to have low amounts of THC and high amounts of CBD.

Topical 40